These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23920992)

  • 21. Measuring the preventability of adverse drug reactions in France: A 2015 overview.
    Olivier-Abbal P
    Therapie; 2016 Apr; 71(2):195-202. PubMed ID: 27080838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital.
    Goldstein LH; Berlin M; Saliba W; Elias M; Berkovitch M
    J Clin Pharmacol; 2013 Nov; 53(11):1220-5. PubMed ID: 23852627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Grouping the pharmacovigilance terms with a hybrid approach.
    Dupuch M; Dupuch L; Perinet A; Hamon T; Grabar N
    Stud Health Technol Inform; 2012; 180():235-9. PubMed ID: 22874187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grouping pharmacovigilance terms with semantic distance.
    Dupuch M; Lerch M; Jamet A; Jaulent MC; Fescharek R; Grabar N
    Stud Health Technol Inform; 2011; 169():794-8. PubMed ID: 21893856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse drug reactions and prescription errors: morbi-mortality].
    Chaio S; Toibaro J; Valicenti P; Saidón P
    Medicina (B Aires); 2013; 73(2):111-8. PubMed ID: 23570758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.
    Baldo P; Francescon S; Fornasier G
    Int J Clin Pharm; 2018 Aug; 40(4):748-753. PubMed ID: 30094557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
    Oliveira JL; Lopes P; Nunes T; Campos D; Boyer S; Ahlberg E; van Mulligen EM; Kors JA; Singh B; Furlong LI; Sanz F; Bauer-Mehren A; Carrascosa MC; Mestres J; Avillach P; Diallo G; Díaz Acedo C; van der Lei J
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):459-67. PubMed ID: 23208789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring brand-name drug mentions on Twitter for pharmacovigilance.
    Carbonell P; Mayer MA; Bravo À
    Stud Health Technol Inform; 2015; 210():55-9. PubMed ID: 25991101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacovigilance of parenterally administered salvianolate based on analysis of spontaneous reporting system data].
    Lu PF; Xiang YY; Xie YM; Chang YP; Wang ZG
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3003-7. PubMed ID: 24471320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating ADR mechanisms with Explainable AI: a feasibility study with knowledge graph mining.
    Bresso E; Monnin P; Bousquet C; Calvier FE; Ndiaye NC; Petitpain N; Smaïl-Tabbone M; Coulet A
    BMC Med Inform Decis Mak; 2021 May; 21(1):171. PubMed ID: 34039343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Direct reporting by patients of adverse drug reactions in Spain].
    Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
    Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacovigilance: Importance, concepts, and processes.
    Kumar A
    Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacy student driven detection of adverse drug reactions in the community pharmacy setting.
    Christensen ST; Søndergaard B; Honoré PH; Bjerrum OJ
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):399-404. PubMed ID: 21442686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network Analyzer.
    Botsis T; Scott J; Goud R; Toman P; Sutherland A; Ball R
    Stud Health Technol Inform; 2014; 205():1178-82. PubMed ID: 25160375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False discovery rate estimation for frequentist pharmacovigilance signal detection methods.
    Ahmed I; Dalmasso C; Haramburu F; Thiessard F; Broët P; Tubert-Bitter P
    Biometrics; 2010 Mar; 66(1):301-9. PubMed ID: 19432790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach.
    Bousquet C; Henegar C; Louët AL; Degoulet P; Jaulent MC
    Int J Med Inform; 2005 Aug; 74(7-8):563-71. PubMed ID: 15955732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rough-set-based ADR signaling from spontaneous reporting data with missing values.
    Lin WY; Lan L; Huang FH; Wang MH
    J Biomed Inform; 2015 Dec; 58():235-246. PubMed ID: 26538119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.
    Motola D; Melis M; Lo Bianco S; Buccellato E; Biagi C; Vaccheri A
    Expert Opin Drug Saf; 2014 Jul; 13(7):867-73. PubMed ID: 24809453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reaction monitoring in a secondary care hospital in South India.
    Arulmani R; Rajendran SD; Suresh B
    Br J Clin Pharmacol; 2008 Feb; 65(2):210-6. PubMed ID: 17662089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Editorial: adverse drug reactions].
    Taegtmeyer AB
    Ther Umsch; 2015 Dec; 72(11-12):667. PubMed ID: 26654808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.